We have seen today a couple of posts from some of the more knowledgable contributors re P/E factors and the size of the targetable Ovarian cancer suffers.
Everything is reliant on CVAC including Prima Biomed's future.
The success and acceptance of CVAC by the world will result in PRR being reclassified....
Primas will not then be known as the "Little Aussie biotech company" but Prima Biomed "the successful developer of CVAC"
the long awaited procedure to make ovarian cancer sufferers life far more comfortable in their latter years.
If this happens Prima will have the runs on the board...They will have a track record of being able to start and finish their research and get their product to market.....
Make no mistake,in the non medical market investors are only focused on one thing "how much can I make out of this?"
The importance of getting CVAC to market will enable us to see possibilities eventuate that we can only dream about.
cvac,the cornerstone of prima biomed....
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.005(1.49%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.0¢ | 33.0¢ | $1.220M | 3.642M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 57289 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 52306 | 3 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |